Insulin × glycemic control

TrialDiabetic medicine : a journal of the British Diabetic Association2007

A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes.

P D Home et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 324 people · 2007

Not counted

Probably lowered glycemic control

−26.6−37.7 to −15.0

As reported

difference −26.6, 95% CI −37.7 to −15.0

One number in the abstract

the abstract, start to end

+/- 3.0 U/day; model-adjusted difference -26.6 (95% CI -37.7, -15,5) U/day, P

← favours treatmentfavours comparator →
could be chance
Glycemic control
−26.6−37.7 to −15.0
MetforminThiazolidinedionesInsulinGlycemic control
1 / 3

6 papers cite it

2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 17403121